Optimizing CAR T-Cell Therapy in DLBCL With Community and Academic Perspectives - Episode 3

Selecting Candidates for CAR T-Cell Therapy in R/R DLBCL: Patient Characteristics, Eligibility, and Timing Considerations

,

Experts discuss the patient factors and disease characteristics that influence the selection of chimeric antigen receptor T-cell therapy (CAR T) options, how to determine if a patient is an appropriate candidate, and when to begin considering CAR T in the treatment journey.

EP. 1: Integrating CAR T-Cell Therapy Into the Treatment Landscape for R/R DLBCL
EP. 2: Bispecific Antibodies vs CAR T-Cell Therapy: Treatment Selection and Sequencing in Later-Line R/R DLBCL
Now Viewing
EP. 3: Selecting Candidates for CAR T-Cell Therapy in R/R DLBCL: Patient Characteristics, Eligibility, and Timing Considerations
EP. 4: Expert Insights for Approaching Patient Counseling for CAR T-Cell Therapy in R/R DLBCL

Video content above is prompted by the following:

  • What patient factors and/or disease characteristics influence your decision when selecting among the currently available CAR T options?
  • How do you determine if a patient is an appropriate candidate for CAR T?
  • At what point in the treatment journey do you begin considering CAR T?
x